1. Academic Validation
  2. LncRNA MIR210HG Facilitates Non-Small Cell Lung Cancer Progression Through Directly Regulation of miR-874/STAT3 Axis

LncRNA MIR210HG Facilitates Non-Small Cell Lung Cancer Progression Through Directly Regulation of miR-874/STAT3 Axis

  • Dose Response. 2020 Jul 10;18(3):1559325820918052. doi: 10.1177/1559325820918052.
Liang Bu 1 Libin Zhang 1 Mei Tian 1 Zhoubin Zheng 1 Huijie Tang 2 Qiuju Yang 2
Affiliations

Affiliations

  • 1 The First People's Hospital of Yunnan Province, Medical School of Kunming University of Science and Technology, Kunming, China.
  • 2 Anesthesiology Department, No.1 People's General Hospital of Yunnan Province, Kunming, Yunnan, China.
Abstract

Background: Long noncoding RNAs are involved in the progression of multiple cancers. However, the expression and mechanism of MicroRNA (miR)210HG in non-small cell lung Cancer (NSCLC) remain unclear.

Methods: The levels of miR210HG and miR-874 were measured by quantitative real-time polymerase chain reaction in NSCLC tissue samples and cells. Non-small cell lung Cancer cell proliferation, migration, and invasion were measured by Cell Counting Kit-8 and transwell assays. Luciferase analysis confirmed the interaction between miR210HG and miR-874.

Results: Here, our data showed that miR210HG was overexpressed in NSCLC tissue samples and cells. In vitro functional assays showed that silencing miR210HG blocked NSCLC cell proliferation, migration, and invasion while promoting NSCLC cell radiosensitivity and chemoresistance. Mechanistically, miR-874 was directly regulated by miR210HG. Furthermore, miR-874 expression was reduced in NSCLC tissues and cells. The miR-874 mimic could mitigate the promoting effect of miR210HG on NSCLC cell progression. The data also showed that miR210HG promoted NSCLC cell progression through miR-181a expression by targeting STAT3.

Conclusions: Our observations suggest that miR210HG is associated with NSCLC cell progression by regulating the miR-874/STAT3 axis.

Keywords

STAT3; invasion; metastasis; miR-874; miR210HG; non-small cell lung cancer.

Figures
Products